Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CCM
stocks logo

CCM

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Valuation Metrics

The current forward P/E ratio for Concord Medical Services Holdings Ltd (CCM.N) is -13.04, compared to its 5-year average forward P/E of -34.57. For a more detailed relative valuation and DCF analysis to assess Concord Medical Services Holdings Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-34.57
Current PE
-13.04
Overvalued PE
-16.46
Undervalued PE
-52.69

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
22.73
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
104.30
Undervalued EV/EBITDA
-58.85

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.54
Current PS
0.00
Overvalued PS
2.70
Undervalued PS
0.39
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

CCM News & Events

Events Timeline

(ET)
2024-12-09
06:42:00
Concord Medical: Application for proton therapy equipment registration approved
select
2024-09-16 (ET)
2024-09-16
08:11:22
Concord Medical obtains procurement license for proton equipment
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
17:53 PMBenzinga
Ulta Beauty Stock Rises Approximately 6%; Check Out 20 Stocks Making Moves in Premarket Trading

  • Ulta Beauty Earnings Report: Ulta Beauty, Inc. reported third-quarter earnings of $5.14 per share, surpassing analyst expectations, and raised its full-year GAAP EPS guidance, leading to a 5.7% increase in share price during pre-market trading.

  • Other Notable Gainers: Several stocks saw significant pre-market gains, including Lion Group Holding Ltd (+57.3%), SMX (+42.9%), and Akanda Corp (+30.1%), following positive developments and shareholder approvals.

  • Stocks Experiencing Losses: Sportsman’s Warehouse Holdings Inc. faced an 18.8% drop after disappointing third-quarter results, while Protara Therapeutics Inc. fell 14.3% due to a public offering announcement.

  • Market Overview: The overall market showed mixed results, with some companies like Rubrik, Inc. and Zumiez Inc. reporting strong earnings and positive outlooks, while others like Hewlett Packard Enterprise Co. and Docusign Inc. reported weaker-than-expected results.

[object Object]
Preview
1.0
12-02PRnewswire
Concord Medical to Hold 2025 Annual Shareholders Meeting on December 29
  • Meeting Schedule: Concord Medical will hold its annual shareholders meeting on December 29, 2025, at 10:00 a.m. in Beijing, allowing shareholders to discuss company affairs with management without any proposals for approval.
  • Record Date: The shareholder record date is set for December 19, 2025, ensuring that all eligible shareholders can participate in the meeting and stay informed about the company's latest developments.
  • Financial Report Disclosure: The company has filed its Form 20-F with the U.S. Securities and Exchange Commission for the fiscal year ended December 31, 2024, which includes audited financial statements, thereby enhancing transparency and investor confidence.
  • Business Background: Concord Medical focuses on providing a full cycle of oncology services, including diagnosis, treatment, education, and prevention, striving to improve the quality and accessibility of cancer care across China.
[object Object]
Preview
9.5
09-26NASDAQ.COM
Concord Medical Services Holdings Ltd. Reports Reduced Losses in H1

  • Financial Performance: Concord Medical Services Holdings Ltd. reported a loss of RMB27.135 million for the first half of the year, an improvement from a loss of RMB172.258 million in the same period last year.

  • Revenue Decline: The company's revenue decreased by 8.3% to RMB200.615 million, down from RMB218.810 million in the previous year.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Concord Medical Services Holdings Ltd (CCM) stock price today?

The current price of CCM is 3.5401 USD — it has decreased -6.23 % in the last trading day.

arrow icon

What is Concord Medical Services Holdings Ltd (CCM)'s business?

Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market.

arrow icon

What is the price predicton of CCM Stock?

Wall Street analysts forecast CCM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCM is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Concord Medical Services Holdings Ltd (CCM)'s revenue for the last quarter?

Concord Medical Services Holdings Ltd revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is Concord Medical Services Holdings Ltd (CCM)'s earnings per share (EPS) for the last quarter?

Concord Medical Services Holdings Ltd. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Concord Medical Services Holdings Ltd (CCM)'s fundamentals?

The market is revising No Change the revenue expectations for CCM for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -35.63%.
arrow icon

How many employees does Concord Medical Services Holdings Ltd (CCM). have?

Concord Medical Services Holdings Ltd (CCM) has 595 emplpoyees as of December 05 2025.

arrow icon

What is Concord Medical Services Holdings Ltd (CCM) market cap?

Today CCM has the market capitalization of 15.37M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free